B
Beatrice Valoriani
Researcher at University of Siena
Publications - 5
Citations - 73
Beatrice Valoriani is an academic researcher from University of Siena. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 2 publications receiving 5 citations.
Papers
More filters
Journal ArticleDOI
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern.
Marco Falcone,Giusy Tiseo,Beatrice Valoriani,Chiara Barbieri,Sara Occhineri,Paola Mazzetti,Maria Linda Vatteroni,Lorenzo Roberto Suardi,Niccolò Riccardi,Mauro Pistello,Danilo Tacconi,Francesco Menichetti +11 more
TL;DR: In this paper, the risk of hospitalization or death in patients infected by SARS-CoV2 variants of concern (VOCs) receiving combinations of monoclonal antibodies (mAbs), bamlanivimab/etesevimab or casirivimabel/imdevimab was evaluated.
Journal ArticleDOI
Safety and Efficacy of Outpatient Treatments for COVID-19: Real-Life Data from a Regionwide Cohort of High-Risk Patients in Tuscany, Italy (the FEDERATE Cohort)
Tommaso Manciulli,Michele Spinicci,Barbara Rossetti,Roberta Maria Antonello,Filippo Lagi,Anna Barbiero,Flavia Chechi,G. Formica,Emanuela Francalanci,Mirco Alesi,Samuele Gaggioli,Giulia Modi,Sara Modica,Riccardo Paggi,Cecilia Costa,Alessandra Morea,L. Paglicci,Ilaria Rancan,Francesco Amadori,Agnese Tamborrino,Marta Tilli,Giulia Bandini,Alberto Moggi Pignone,Beatrice Valoriani,Francesca Montagnani,Mario Tumbarello,Pierluigi Blanc,M. Di Pietro,Luisa Galli,D. Aquilini,Antonella Vincenti,S. Sani,Cesira Nencioni,S. Luchi,D. Tacconi,Lorenzo Zammarchi,A. Bartoloni +36 more
TL;DR: In this article , a multicenter study presented real-life data on COVID-19 early treatments in 11 infectious diseases units in the Tuscany region of Italy between 1 January and 31 March 2022, when Omicron sublineages BA.1 and BA.2 were circulating.
Journal ArticleDOI
Impact of healthcare-associated infections on functional outcome of severe acquired brain injury during inpatient rehabilitation
Michelangelo Bartolo,Chiara Zucchella,Hend Aabid,Beatrice Valoriani,Massimiliano Copetti,Andrea Fontana,Domenico Intiso,Mauro Mancuso +7 more
TL;DR: A multicenter observational study with severe acquired brain injury (sABI) patients was performed as discussed by the authors , where patients were divided into infected (INF-group) or not infected (noINF)-group and assessed at admission and discharge, by means of the Glasgow Coma Scale (GCS), the Rancho Los Amigos Levels of Cognitive Functioning Scale (LCF), the Disability Rating Scale (DRS), and the modified Barthel Index (mBI).
Journal ArticleDOI
Impact of healthcare-associated infections on functional outcome of severe acquired brain injury during inpatient rehabilitation
Michelangelo Bartolo,Chiara Zucchella,Hend Aabid,Beatrice Valoriani,Massimiliano Copetti,Andrea Fontana,Domenico Intiso,Mauro Mancuso +7 more
TL;DR: A multicenter observational study with severe acquired brain injury (sABI) patients was performed as discussed by the authors , where patients were divided into infected (INF-group) or not infected (noINF)-group and assessed at admission and discharge, by means of the Glasgow Coma Scale (GCS), the Rancho Los Amigos Levels of Cognitive Functioning Scale (LCF), the Disability Rating Scale (DRS), and the modified Barthel Index (mBI).
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection.
Alessandra Vergori,Barbara Rossetti,Ilaria Vicenti,Genny Meini,Gianluca Lentini,Beatrice Valoriani,C. Caudai,Matteo Morandi,Maria Grazia Cusi,Maurizio Zazzi,Andrea De Luca +10 more
TL;DR: Lower levels of qHBsAg were associated in the whole study population and in the untreated patients' subgroup with specific IL28-SNP haplogroups might be associated with lower q HBsAg, in multivariate analysis.